Renaissance Capital logo

ARYx Therapeutics , Nasdaq: ARYX

Re-engineering commercially successful drugs to eliminate safety issues.

Industry: Health Care

First Day Return: -19.0%

Industry: Health Care

Re-engineering commercially successful drugs to eliminate safety issues.
more less

ARYx Therapeutics (ARYX) Performance